An APL Case without a Detectable RARA Gene Rearrangement Read more about An APL Case without a Detectable RARA Gene Rearrangement
CD49d Expression in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma: A Reference Laboratory Perspective Read more about CD49d Expression in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma: A Reference Laboratory Perspective
MDS Diagnosis Using cfRNA Profiling By Targeted Enrichment Next Generation Sequencing Read more about MDS Diagnosis Using cfRNA Profiling By Targeted Enrichment Next Generation Sequencing
Liquid Biopsy As a Diagnostic Test for Myelodysplastic Syndrome and Other Acute and Chronic Myeloid Neoplasms Read more about Liquid Biopsy As a Diagnostic Test for Myelodysplastic Syndrome and Other Acute and Chronic Myeloid Neoplasms
FLT3 Mutation in Acute Myeloid Leukemia: Primary or Secondary Mutation? Read more about FLT3 Mutation in Acute Myeloid Leukemia: Primary or Secondary Mutation?
Clonal Hematopoiesis in Normal Individuals Is Not Random and Likely Reflects Early MDS Read more about Clonal Hematopoiesis in Normal Individuals Is Not Random and Likely Reflects Early MDS
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia Read more about Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia
Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors Read more about Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors
Wild-type blocking PCR combined with direct sequencing as a highly sensitive method for detection of low-frequency somatic mutations Read more about Wild-type blocking PCR combined with direct sequencing as a highly sensitive method for detection of low-frequency somatic mutations
Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits Read more about Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits